Avalo Therapeutics
AVTX
AVTX
18 hedge funds and large institutions have $18.4M invested in Avalo Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
92% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 26
Holders
18
Holding in Top 10
–
Calls
$6K
Puts
–
Top Buyers
| 1 | +$52K | |
| 2 | +$26.9K | |
| 3 | +$19.6K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$4K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.38K |
Top Sellers
| 1 | -$225K | |
| 2 | -$170K | |
| 3 | -$142K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$112K |
| 5 |
Millennium Management
New York
|
-$109K |